Do cyclin-dependent kinase (CDK) 4/6 inhibitors cause acute kidney injury (AKI)? #onconephrology #Thread

A little #tweetorial about CDK 4/6 inhibitor-associated AKI: what we know already, and what we found
kireports.org/article/S2468-…
3 CDK 4/6 inhibitors (palbociclib, ribociclib, and abemaciclib)have been approved for HER2-negative metastatic breast cancers. CDK 4/6 inhibitors help overcome resistance to endocrine therapies by preventing cell-cycle progression and cancer growth (frontiersin.org/articles/10.33…).
What do we know about AKI related to CDK 4/6 inhibition? In vitro studies suggest that CDK 4/6 inhibitor metabolites inhibit renal transporters, potentially leading to a reversible rise in serum creatinine (SCr) without actually changing GFR (ncbi.nlm.nih.gov/pmc/articles/P…).
Our objective: to present the first series of patients with biopsy-proven AKI associated with CDK4/6 inhibitors, with a focus on clinical features and pathologic findings, and to query the FAERS database for renal adverse events related to CDK 4/6 inhibitors
Histopathology: 6 patients treated at 3 different centers had biopsy-proven AKI that was directly attributable to the CDK 4/6 inhibitor by the treating nephrologist. Acute tubular injury was the most common pathology, though one patient had acute tubulointerstitial nephritis
Repercussions of AKI: AKI required dose reduction and or discontinuation of therapy in 4 of 6 patients
Reporting of renal related adverse events: The most common renal adverse event was renal injury, but electrolyte abnormalities were reported as well, including hypokalemia, hyponatremia, and hypocalcemia
Though CDK4/6 inhibitors may lead to a reversible rise in SCr, they can also cause true renal tubular toxicity and metabolic disturbances. We now need larger, prospective studies to understand and characterize the incidence of and risk factors for AKI
This collaborative effort would not have been possible without @kdjhaveri, @Tiff_Caza, @herrmannMd, and Vipul Sakhiya. @bwhkidney, #HofNorthwellDOM, @NorthwellHealth, @arkanalabs, @MayoClinicNeph, @KIReports
And thank you to @edgarvlermamd for this stunning visual abstract @threadreaderapp #unroll

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Shruti Gupta

Shruti Gupta Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ShrutiGkidney

8 Oct
*NEW ARTICLE*
What does a nephrologist need to know about immune checkpoint inhibitor-associated AKI (ICPi-AKI)?@DavidLeaf9 #Thread
my first #tweetorial with help from @kdjhaveri
jitc.bmj.com/content/9/10/e… (1/11)
Why does it matter? ICPi-AKI can lead to:
*Discontinuation of ICPi therapy
*Irreversible loss of kidney function
*Prolonged courses of immunosuppression (2/11)
We conducted a multicenter study of 429 patients with ICPi-AKI from 30 sites across 10 countries, along with 429 control patients who received ICPis contemporaneously but did not develop ICPi-AKI. This is the largest study to date on ICPi-AKI (3/11)
Read 11 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(